Sherbrooke Park Advisers LLC Corcept Therapeutics Inc Call Options Transaction History
Sherbrooke Park Advisers LLC
- $313 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CORT
# of Institutions
409Shares Held
84.9MCall Options Held
1.04MPut Options Held
1.33M-
Black Rock Inc. New York, NY16.5MShares$904 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$553 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.1MShares$442 Million16.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.2MShares$339 Million0.49% of portfolio
-
Parallel Advisors, LLC3.97MShares$217 Million5.04% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $5.85B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...